Hims stock rose Monday after the telehealth program named technology industry veteran Nader Kabbani as its new chief operating officer.

Hims & Hers Health (NYSE: HIMS) will report its Q1 2025 financial results today, after the market closes with a conference ...

Hims & Hers Health shares are trading marginally lower Monday morning. The company earlier appointed Nader Kabbani as its new ...

Hims & Hers Health Inc. (NYSE:HIMS) partners with Novo Nordisk to offer affordable weight-loss drug, positioning itself to ...

Hims & Hers Health on Monday announced Nader Kabbani, a former Amazon executive who helped establish many of its health-care ...

Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...

Novo Nordisk said it would sell its popular weight-loss drug Wegovy on several telehealth platforms, including Hims.

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Nader ...

Then, early last month, President Donald Trump announced expansive new tariffs on much of the world. Adjustments and carve-outs followed. But from March 31 to April 30, the report said, Wall Street ...

Then, early last month, President Donald Trump announced expansive new tariffs on much of the world. Adjustments and carve-outs followed. But from March 31 to April 30, the report said, Wall Street ...

About Hims & Hers Health Inc. Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for ...

Hims & Hers Health (NYSE:HIMS) stock spikes, risking a short squeeze given its elevated short interest. Read more here.